识别活检分级分组升级至2级前列腺癌后仍可安全接受主动监测的男性
研究纳入249例接受根治性前列腺切除术的主动监测患者,比较监测活检为分级分组1级或2级者的术后不良病理。含前列腺特异性抗原密度和神经周围侵犯的模型可分层不良病理风险;57%(39/68)监测中升级至2级的1级患者术后病理为有利。
要点
- 监测中升级至分级分组2级者,多数术后病理为有利,可继续主动监测。
- 低前列腺特异性抗原密度且无神经周围侵犯的升级至2级者,术后不良病理风险最低。
- 仅凭升级至分级分组2级不应取消主动监测资格。
核心结论
- 多数进入主动监测后升级至分级分组2级的1级患者根治性前列腺切除标本为有利病理,可继续主动监测。
- 升级至2级者中,低前列腺特异性抗原密度且无神经周围侵犯者术后不良病理风险最低,与未升级的1级患者相当或更低。
- 仅升级至分级分组2级本身不应使男性失去继续主动监测的资格。
研究设计与样本
- 研究249例接受根治性前列腺切除术的主动监测患者,其监测活检为分级分组1级或2级。
- 评估神经周围侵犯、癌体积、Gleason 4级的线性长度与最大百分比及前列腺特异性抗原密度。
- 根治性前列腺切除不良病理定义为以下任一:pN1;≥pT3;≥分级分组2级且Gleason 4级≥20%;导管内癌;大筛状腺体。
主要发现
- 含前列腺特异性抗原密度和神经周围侵犯的多变量逻辑回归模型可在分级分组1级和2级主动监测患者中分层根治性前列腺切除不良病理风险。
- 57%(39/68)监测中升级至分级分组2级的1级患者根治性前列腺切除病理为有利。
- 无活检神经周围侵犯且前列腺特异性抗原密度低者更可能有有利的根治性前列腺切除病理。
关键数值与推荐
- 根治性前列腺切除不良病理定义:pN1;≥pT3;≥分级分组2级且Gleason 4级≥20%;导管内癌;大筛状腺体。
- 57%(39/68)为监测中升级至分级分组2级的1级患者中术后病理有利的比例。
临床怎么用
- 前列腺特异性抗原密度和神经周围侵犯可在升级至分级分组2级的主动监测患者中分层风险。
- 若与其他临床病理和影像学发现一致,这些指标可使更多患者继续主动监测。
- 仅升级至分级分组2级不应取消男性继续主动监测的资格。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Men on active surveillance with Grade Group 1 prostate cancer who reclassify to Grade Group 2 on surveillance biopsy often leave active surveillance. We aimed to identify subgroups of men who can safely remain on active surveillance despite preoperative reclassification to Grade Group 2. MATERIALS AND METHODS: We studied 249 active surveillance patients with surveillance biopsies classified as Grade Group 1 or Grade Group 2 who underwent radical prostatectomy. Perineural invasion, cancer volume, linear length and maximum percentage of Gleason pattern 4, and prostate-specific antigen density were evaluated. Radical prostatectomy adverse pathology was defined by any of: pN1; ≥pT3; ≥Grade Group 2 with ≥20% Gleason pattern 4; intraductal carcinoma; large cribriform glands. RESULTS: A multivariable logistic regression model incorporating prostate-specific antigen density and perineural invasion stratified radical prostatectomy adverse pathology risk among Grade Group 1 and Grade Group 2 active surveillance patients. 57% (39/68) of Grade Group 1 men reclassified to Grade Group 2 while on active surveillance had favorable radical prostatectomy pathology. Those without biopsy perineural invasion and with low prostate-specific antigen density were more likely to have favorable radical prostatectomy pathology. CONCLUSIONS: Most Grade Group 1 men who enter active surveillance and subsequently reclassify to Grade Group 2 have favorable findings at radical prostatectomy and can remain on active surveillance. Among patients reclassified to Grade Group 2, those with low prostate-specific antigen density and without perineural invasion had the lowest risk of radical prostatectomy adverse pathology, comparable to (or below) that of Grade Group 1 patients who were not reclassified to Grade Group 2 preoperatively. Prostate-specific antigen density and perineural invasion stratify risk in active surveillance patients reclassified to Grade Group 2 and, if concordant with other clinicopathological and radiographic findings, can enable more patients to remain on active surveillance. Reclassification to Grade Group 2 alone should not disqualify men from remaining on active surveillance.
引用
- Baraban E, Erak E, Fatima A, et al. Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer. J Urol. 2023. PMID: 37042826. doi:10.1097/JU.0000000000003461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。